• News
  • SAN DIEGO
  • Health

Sorrento Therapeutics adds Amar Singh as executive VP

Sorrento Therapeutics Inc. (Nasdaq: SRNE) has appointed Amar Singh to be its executive vice president and chief business officer, the late-stage clinical oncology company reported Wednesday.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Sorrento Therapeutics Inc.

Company Website

6042 Cornerstone Ct. West Ste., B
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
SRNE
4.17
  0.13  
+ 3.22%
203,200,000
16.40
3.10

Sorrento Therapeutics Inc. Executive(s):

Henry Ji

  • Chief Executive Officer

Richard Vincent

  • Chief Financial Officer

Similar Companies

NAICS - 541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
SIC - 3764 - GUIDED MISSILE AND SPACE VEHICLE PROPULSION UNITS AND PROPULSION
SIC - 3728 - AIRCRAFT PARTS AND AUXILIARY EQUIPMENT, NOT ELSEWHERE CLASSIFIED
SIC - 3769 - GUIDED MISSILE AND SPACE VEHICLE PARTS AND AUXILIARY EQUIPMENT, N
SIC - 3721 - AIRCRAFT
SIC - 3761 - GUIDED MISSILES AND SPACE VEHICLES
Subscribe Today!